Chronic granulomatous disease in adults - PubMed (original) (raw)
Chronic granulomatous disease in adults
J G Liese et al. Lancet. 1996.
Abstract
Background: Chronic granulomatous disease (CGD), an inherited disorder of granulocyte function caused by failure of intracellular superoxide production, normally presents in the first years of life with severe recurrent bacterial and fungal infections.
Methods: From the files of two children's hospitals we identified 11 CGD patients who were remarkable for an unusually late diagnosis, at 13-43 years of age. Their clinical and laboratory features were examined.
Findings: The first clinical manifestation occurred at a median age of 3.6 years but CGD was not diagnosed until a median age of 22 years. Pneumonias and abscesses caused by Staphylococcus aureus and Aspergillus species were the most frequent infections. Granulomas, often leading to chronic complications, occurred in 7 of the patients. With 1.1 severe infections in 100 patient months, the 11 patients had a lower frequency of severe infections than patients with classic CGD; however, such infections could be equally life-threatening. 8 of the patients had X-linked CGD with small but detectable quantities of cytochrome b558, normally absent in X-linked CGD; and 3 had autosomal-recessive CGD. 9 patients had residual production of reactive oxygen metabolites, a feature that could explain the low incidence of infections.
Interpretation: CGD in adults may be more common than previously assumed. In view of the possibility of timely treatment, infection prophylaxis, and genetic counselling for affected families, CGD should be excluded in any patient with unexplained infections or granulomas.
Comment in
- Testing for chronic granulomatous disease.
Vowells SJ, Fleisher TA, Malech HL. Vowells SJ, et al. Lancet. 1996 Apr 13;347(9007):1048-9. doi: 10.1016/s0140-6736(96)90189-0. Lancet. 1996. PMID: 8606593 No abstract available.
Similar articles
- Common Infections and Target Organs Associated with Chronic Granulomatous Disease in Iran.
Mortaz E, Azempour E, Mansouri D, Tabarsi P, Ghazi M, Koenderman L, Roos D, Adcock IM. Mortaz E, et al. Int Arch Allergy Immunol. 2019;179(1):62-73. doi: 10.1159/000496181. Epub 2019 Mar 22. Int Arch Allergy Immunol. 2019. PMID: 30904913 Review. - Phenomic Analysis of Chronic Granulomatous Disease Reveals More Severe Integumentary Infections in X-Linked Compared With Autosomal Recessive Chronic Granulomatous Disease.
Chiu TL, Leung D, Chan KW, Yeung HM, Wong CY, Mao H, He J, Vignesh P, Liang W, Liew WK, Jiang LP, Chen TX, Chen XY, Tao YB, Xu YB, Yu HH, Terblanche A, Lung DC, Li CR, Chen J, Tian M, Eley B, Yang X, Yang J, Chiang WC, Lee BW, Suri D, Rawat A, Gupta A, Singh S, Wong WHS, Chua GT, Duque JSDR, Cheong KN, Chong PC, Ho MH, Lee TL, Yang W, Lee PP, Lau YL. Chiu TL, et al. Front Immunol. 2022 Jan 24;12:803763. doi: 10.3389/fimmu.2021.803763. eCollection 2021. Front Immunol. 2022. PMID: 35140711 Free PMC article. - Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
Ezekowitz RA, Orkin SH, Newburger PE. Ezekowitz RA, et al. J Clin Invest. 1987 Oct;80(4):1009-16. doi: 10.1172/JCI113153. J Clin Invest. 1987. PMID: 2821069 Free PMC article. - Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
Köker MY, Camcıoğlu Y, van Leeuwen K, Kılıç SŞ, Barlan I, Yılmaz M, Metin A, de Boer M, Avcılar H, Patıroğlu T, Yıldıran A, Yeğin O, Tezcan I, Sanal Ö, Roos D. Köker MY, et al. J Allergy Clin Immunol. 2013 Nov;132(5):1156-1163.e5. doi: 10.1016/j.jaci.2013.05.039. Epub 2013 Jul 31. J Allergy Clin Immunol. 2013. PMID: 23910690 - Seven chronic granulomatous disease cases in a single-center experience and a review of the literature.
Kutluğ Ş, Şensoy G, Birinci A, Saraymen B, Yavuz Köker M, Yιldιran A. Kutluğ Ş, et al. Asian Pac J Allergy Immunol. 2018 Mar;36(1):35-41. doi: 10.12932/AP0859. Asian Pac J Allergy Immunol. 2018. PMID: 28577521 Review.
Cited by
- Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry.
Jones LB, McGrogan P, Flood TJ, Gennery AR, Morton L, Thrasher A, Goldblatt D, Parker L, Cant AJ. Jones LB, et al. Clin Exp Immunol. 2008 May;152(2):211-8. doi: 10.1111/j.1365-2249.2008.03644.x. Clin Exp Immunol. 2008. PMID: 18410635 Free PMC article. - The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders.
Arts RJW, Joosten LAB, Netea MG. Arts RJW, et al. Front Immunol. 2018 Feb 20;9:298. doi: 10.3389/fimmu.2018.00298. eCollection 2018. Front Immunol. 2018. PMID: 29515591 Free PMC article. Review. - Recent advances in understanding and treating chronic granulomatous disease.
Gennery A. Gennery A. F1000Res. 2017 Aug 11;6:1427. doi: 10.12688/f1000research.11789.1. eCollection 2017. F1000Res. 2017. PMID: 28868142 Free PMC article. Review. - Respiratory Complications Lead to the Diagnosis of Chronic Granulomatous Disease in Two Adult Patients.
Colin de Verdière S, Noel E, Lozano C, Catherinot E, Martin M, Rivaud E, Couderc LJ, Salvator H, Bustamante J, Martin T. Colin de Verdière S, et al. J Clin Immunol. 2017 Feb;37(2):113-116. doi: 10.1007/s10875-017-0370-1. Epub 2017 Jan 27. J Clin Immunol. 2017. PMID: 28130637 - Fatal acute granulomatous pulmonary aspergillosis in a healthy subject after inhalation of vegetal dust.
Batard E, Renaudin K, Morin O, Desjars P, Germaud P. Batard E, et al. Eur J Clin Microbiol Infect Dis. 2003 Jun;22(6):357-9. doi: 10.1007/s10096-003-0939-x. Epub 2003 May 28. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12774197
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources